Back

Phenotypic expression and outcomes of cardiomyopathy caused by titin truncating variants: translational insights

20 May 2023 (10:26 - 10:37)
Organised by: Logo
Congress Presentation Part of: Novelties in amyloid cardiomyopathy Clinical HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Maria Perotto

Giuliano Isontina University Health Authority, Trieste (Italy)

3 More presentations in this session

Presentation thumbnail
Use and safety of sodium-glucose cotransporter 2 inhibitors in a prospective cohort of patients with transthyretin amyloid cardiomyopathy.
Doctor M. Maccallini (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis
Doctor V. Castiglione (Pisa, IT) Associate Professor G. Vergaro (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/SPAP) ratio in amyloid cardiomyopathy
Doctor M. Maccallini (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Novelties in amyloid cardiomyopathy
Video

The Event

Event poster

Heart Failure 2023

20 May 2023 10:26 CET
You may be interested in
thumbnail
Congress Presentation
Insights on Titin cardiomyopathy: from truncating variants site to phenotypic expression and outcomes
thumbnail
Congress Presentation
Targeting titin in dilated cardiomyopathy
thumbnail
Congress Session
Improved understanding of the genetic background of cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources